Blog
RSS FeedPosted by Michael Wonder on 03 Sep 2016
FDA allows marketing of clot retrieval devices to reduce disability in stroke patients
2 September 2016 - The U.S. FDA today allowed marketing of two Trevo clot retrieval devices as an initial therapy for ...
Posted by Michael Wonder on 30 Aug 2016
CADTH recommends Brilinta (ticagrelor)
25 August 2016 - CADTH has recommended the reimbursement of AstraZeneca's Brilinta (ticagrelor) for the secondary prevention of atherothrombotic events. ...
Posted by Michael Wonder on 12 Aug 2016
Thousands to benefit as NICE set to recommend drug to prevent heart attacks and strokes
12 August 2016 - NICE has published draft guidance recommending anti-clotting drug ticagrelor 60 mg with aspirin for people who have ...
Posted by Michael Wonder on 11 Aug 2016
The future of cardiovascular medicine from the regulatory perspective
10 August 2016 - For many years, the American public and the entire world have benefited from the U.S. FDAs’ regulatory ...
Posted by Michael Wonder on 15 Jun 2016
$4.5 million behind new pill to tackle Australia’s number one killer
15 June 2016 - A new pill designed to reduce the devastating toll of heart disease and stroke in Australia and ...